Sequent Scientific Limited (SEQUENT.BO)
INR 181.65
(-0.6%)
INR 181.65
(-0.6%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 13.69 Billion | 14.18 Billion | 14.1 Billion | 13.52 Billion | 11.6 Billion | 10.21 Billion |
| Cost of Revenue | 10.71 Billion | 8.98 Billion | 8.44 Billion | 7.36 Billion | 6.38 Billion | 5.74 Billion |
| Gross Profit | 2.97 Billion | 5.19 Billion | 5.65 Billion | 6.15 Billion | 5.22 Billion | 4.47 Billion |
| Operating Expenses | 2.9 Billion | 5.19 Billion | 4.98 Billion | 4.4 Billion | 3.76 Billion | 3.44 Billion |
| Selling, General and Administrative Expenses | 2.9 Billion | 821.59 Million | 777.07 Million | 672.44 Million | 618.27 Million | 452.43 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -123.49 Million | -51.74 Million | -30.79 Million | -83.07 Million | -60.99 Million |
| Cost and Expenses | 13.62 Billion | 14.17 Billion | 13.42 Billion | 11.76 Billion | 10.14 Billion | 9.18 Billion |
| Operating Income | - | -97.37 Million | 355.94 Million | 1.55 Billion | 1.07 Billion | 826.17 Million |
| Interest Expense | 480.86 Million | 297.19 Million | 135.09 Million | 192.54 Million | 327.02 Million | 287.5 Million |
| Income Tax Expense | -250.33 Million | -156.81 Million | 81.66 Million | 321.77 Million | 120.29 Million | 20.07 Million |
| Earnings before Tax | -546.46 Million | -1.37 Billion | 529.3 Million | 1.36 Billion | 940.75 Million | 588.84 Million |
| Net Income | -358.69 Million | -1.21 Billion | 409.55 Million | 954.42 Million | 699.05 Million | 486.6 Million |
| Earnings Per Share Basic | -1.44 | -4.88 | 1.67 | 3.87 | 2.87 | 2.00 |
| Earnings Per Share Diluted | -1.44 | -4.84 | 1.65 | 3.85 | 2.85 | 1.99 |
| Weighted Average Shares Outstanding | 249.09 Million | 248.47 Million | 247.4 Million | 246.87 Million | 243.43 Million | 242.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 249.09 Million | 250.11 Million | 250.73 Million | 247.87 Million | 245.3 Million | 243.98 Million |
| Gross Margin | 0.22 | 0.37 | 0.40 | 0.46 | 0.45 | 0.44 |
| EBIT Margin | 0.04 | -0.01 | 0.08 | 0.16 | 0.16 | 0.13 |
| Profit Margin | -0.03 | -0.09 | 0.03 | 0.07 | 0.06 | 0.05 |
| EBITDA | 549.8 Million | -464.48 Million | 1.2 Billion | 2.11 Billion | 1.8 Billion | 1.33 Billion |
| Earnings Before Tax Margin | - | -0.01 | 0.03 | 0.11 | 0.09 | 0.08 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 3.9 Billion | 13.69 Billion | 3.61 Billion | 3.29 Billion | 3.45 Billion | 3.33 Billion |
| Cost of Revenue | 2.92 Billion | 10.71 Billion | 2.73 Billion | 1.8 Billion | 1.89 Billion | 1.94 Billion |
| Gross Profit | 976.2 Million | 2.97 Billion | 879.86 Million | 1.48 Billion | 1.56 Billion | 1.38 Billion |
| Operating Expenses | 711.4 Million | 2.9 Billion | 702.13 Million | 1.41 Billion | 1.53 Billion | 1.58 Billion |
| Selling, General and Administrative Expenses | 711.4 Million | - | 702.13 Million | 679.76 Million | 722.5 Million | 797.42 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 26.8 Million | 109.57 Million | 39.98 Million | 22.2 Million | 16.48 Million | 7.93 Million |
| Cost and Expenses | 3.63 Billion | 13.62 Billion | 3.43 Billion | 3.21 Billion | 3.43 Billion | 3.52 Billion |
| Operating Income | 264.8 Million | 76.92 Million | 177.73 Million | 90.14 Million | 22.3 Million | -197.48 Million |
| Interest Expense | 163.8 Million | 480.86 Million | 124.41 Million | 125.81 Million | 125.8 Million | 104.84 Million |
| Income Tax Expense | 29.4 Million | -250.33 Million | 13.62 Million | -91.85 Million | 37.88 Million | -209.96 Million |
| Earnings before Tax | 120 Million | -546.46 Million | 26.36 Million | 14.91 Million | -30.94 Million | -556.79 Million |
| Net Income | 65.1 Million | -358.69 Million | -9.11 Million | 82.68 Million | -83.8 Million | -348.46 Million |
| Earnings Per Share Basic | 0.26 | - | -0.04 | 0.33 | -0.34 | -1.40 |
| Earnings Per Share Diluted | 0.26 | - | -0.04 | 0.33 | -0.34 | -1.40 |
| Weighted Average Shares Outstanding | 248.53 Million | 248.47 Million | 248.47 Million | 248.47 Million | 248.46 Million | 248.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 248.53 Million | 248.47 Million | 248.47 Million | 248.47 Million | 248.46 Million | 248.46 Million |
| Gross Margin | 0.25 | 0.22 | 0.24 | 0.45 | 0.45 | 0.42 |
| EBIT Margin | 0.11 | - | 0.09 | 0.07 | 0.05 | -0.02 |
| Profit Margin | 0.02 | -0.03 | -0.00 | 0.03 | -0.02 | -0.10 |
| EBITDA | 427.3 Million | - | 342.57 Million | 244.69 Million | 167.79 Million | -74.43 Million |
| Earnings Before Tax Margin | 0.07 | 0.01 | 0.05 | 0.03 | 0.01 | -0.06 |
DOSEF
EDEN
ORDS
EXPL
5237
600977